JP2007522141A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522141A5
JP2007522141A5 JP2006551821A JP2006551821A JP2007522141A5 JP 2007522141 A5 JP2007522141 A5 JP 2007522141A5 JP 2006551821 A JP2006551821 A JP 2006551821A JP 2006551821 A JP2006551821 A JP 2006551821A JP 2007522141 A5 JP2007522141 A5 JP 2007522141A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally
substituted
alkoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006551821A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522141A (ja
Filing date
Publication date
Priority claimed from GBGB0402797.5A external-priority patent/GB0402797D0/en
Application filed filed Critical
Publication of JP2007522141A publication Critical patent/JP2007522141A/ja
Publication of JP2007522141A5 publication Critical patent/JP2007522141A5/ja
Pending legal-status Critical Current

Links

JP2006551821A 2004-02-09 2005-02-08 呼吸器疾患の処置のためのベンゾチアゾール−2−オンベータ2アドレナリン受容体アゴニストとコルチコステロイドの組合せ剤 Pending JP2007522141A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402797.5A GB0402797D0 (en) 2004-02-09 2004-02-09 Organic compounds
PCT/EP2005/001241 WO2005074924A1 (en) 2004-02-09 2005-02-08 Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases

Publications (2)

Publication Number Publication Date
JP2007522141A JP2007522141A (ja) 2007-08-09
JP2007522141A5 true JP2007522141A5 (https=) 2008-03-21

Family

ID=31985893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551821A Pending JP2007522141A (ja) 2004-02-09 2005-02-08 呼吸器疾患の処置のためのベンゾチアゾール−2−オンベータ2アドレナリン受容体アゴニストとコルチコステロイドの組合せ剤

Country Status (13)

Country Link
EP (1) EP1715860A1 (https=)
JP (1) JP2007522141A (https=)
KR (1) KR20060127974A (https=)
CN (1) CN1917875A (https=)
AR (1) AR047962A1 (https=)
AU (1) AU2005210140A1 (https=)
BR (1) BRPI0507544A (https=)
CA (1) CA2552938A1 (https=)
GB (1) GB0402797D0 (https=)
PE (1) PE20050692A1 (https=)
RU (1) RU2006132195A (https=)
TW (1) TW200536533A (https=)
WO (1) WO2005074924A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
ATE529399T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702456D0 (en) * 2007-02-08 2007-03-21 Astrazeneca Ab New combination
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
EP2011534A1 (en) * 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Metered dose inhaler actuator
JP4686650B2 (ja) 2007-11-30 2011-05-25 ファイザー・リミテッド 新規なグルココルチコイド受容体アゴニスト
JP5570996B2 (ja) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド エアロゾル化可能な食料品の送達
MX2010007604A (es) 2008-01-11 2010-08-02 Novartis Ag Pirimidinas como inhibidores de cinasa.
WO2009154557A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
WO2012116217A1 (en) 2011-02-25 2012-08-30 Irm Llc Compounds and compositions as trk inhibitors
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
MY194619A (en) 2016-06-02 2022-12-07 Abbvie Inc Glucocorticoid receptor agonist and immunoconjugates thereof
AU2018374634A1 (en) 2017-12-01 2020-05-28 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (en) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha BENZOTHIAZOLONE DERIVATIVES HAVING SELECTIVE β2 RECEPTOR AGONIST ACTIVITY
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos

Similar Documents

Publication Publication Date Title
JP2007522141A5 (https=)
JP2004514739A5 (https=)
RU2006132195A (ru) Комбинация агонистов бета-2 адренорецептора, бензотиазол-2-онов и кортикостероидов, предназначенная для лечения респираторных заболеваний
CA2427282A1 (en) Mixtures or organic compounds for the treatment of airway diseases
JP2018199684A5 (https=)
JP2010215637A (ja) β2−アゴニストの溶液を含有する加圧式定量用量吸入器
WO2012047674A2 (en) Methods and compositions for disease treatment using inhalation
JP2017528479A (ja) Rpl554を含む液体吸入製剤
UA82217C2 (uk) Медикамент, що містить бета2-агоніст у комбінації з будезонідом, для лікування запальних або обструктивних хвороб дихальних шляхів
WO2011136754A1 (en) A medicament developed for the treatment of respiratory diseases
JP2015519356A5 (https=)
CN103582477A (zh) 包含芜地溴铵和皮质类固醇的组合
RU2008124833A (ru) Лечение астмы и хронического обструктивного заболевания легких с использованием тройных комбинаций
JP2020023537A (ja) Copdの治療のためのチオトロピウムブロミド、フォルモテロール及びブデソニドの組み合わせ
PT2398473E (pt) 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1- hidroxietil)-8-hidroxiquinolin-2(1h)-ona para o tratamento da função pulmonar
WO2011136753A1 (en) Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
TWI436761B (zh) 使用噻唑衍生物之方法
JP5501451B2 (ja) 咳の治療のためのテオブロミン
JP2004500434A (ja) サルメテロールとブデソニドを含む組合せ医薬
CA2972939A1 (en) Pharmaceutical combination
JP2023524064A (ja) ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法
JP2011500731A5 (https=)
RU2010120806A (ru) Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид
ES2917879T3 (es) Nuevo uso de aclidinio
JP6863984B2 (ja) 結晶多形とプロセス